Latest News
Astronomical Prices of Some Cancer Drugs Hit Vulnerable Patients Hard
60 Minutes reported last Sunday on the high price of cancer drugs in the U.S. Lesley Stahl’s piece shed light on the fact that Medicare has to pay the price determined by the drug companies, since under current law, Medicare is prohibited from negotiating the prices. The report noted that some cancer patients have gone into bankruptcy in an effort to save their lives. Dr. Leonard Saltz, chief of gastrointestinal oncology at Memorial Sloan Kettering, noted that a patient could easily be paying $250,000 for two drugs, “just to get started.”..Read More